IceCure Medical Ltd.
ICCMDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
Get an email about ICCM's next catalysts
Track IceCure Medical (ICCM) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 0 past
ICCM Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.83 | FQ end Sep/2026 | Call: tbd
How ICCM's past catalysts played out
No drugs found in this phase.
Breast cancer treatment de-escalation
1 drug in this indication
Breast cancer cryoablation
1 drug in this indication
Low-risk breast cancer cryoablation treatment
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
When is IceCure Medical Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for IceCure Medical Ltd. (ICCM) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ICCM biotech catalysts?→
Add ICCM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow IceCure Medical Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.